ravidasvir
Sign in to saveRavidasvir (PPI-668) is an investigational NS5A inhibitor (by Pharco Pharmaceuticals) in clinical trials for chronic hepatitis C genotype 4.
In the Vinony graph
Within Vinony's link graph, ravidasvir is referenced by 103 other articles, and connects out to Russia, World Health Organization and medication.
Vinony files it under Chemical pages without DrugBank identifier, Drugs with no legal status and Experimental antiviral drugs.
Its subject is documented across 10 Wikipedia language editions.
Wikidata facts
- Mass
- 762.385
Show 4 more facts
- canonical SMILES
- CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
- chemical formula
- C₄₂H₅₀N₈O₆
- isomeric SMILES
- CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)[C@@H]7CCCN7C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
- World Health Organisation international non-proprietary name
- ravidasvir
Sources (1)
via Wikidata · CC0
~3 min read
Encyclopedic overview
1 sectionsContents
- References
{{Drugbox | Verifiedfields = | Watchedfields = | verifiedrevid = | IUPAC_name = (2S)-2-{[Hydroxy(methoxy)methylidene]amino}-1-[(2S)-2-[5-(6-{2-[(2S)-1-[(2S)-2-{[hydroxy(methoxy)methylidene]amino}-3-methylbutanoyl]pyrrolidin-2-yl]-1H-1,3-benzodiazol-6-yl}naphthalen-2-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methylbutan-1-one | image = Ravidasvir.svg | image_class = skin-invert-image | width = 275
| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =
Excerpted from Wikipedia’s “ravidasvir” article, available under the CC BY-SA 4.0 licence.